Ritholtz Wealth Management’s Cabaletta Bio CABA Stock Holding History

Ritholtz Wealth Management’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$77.8K	Buy	+25,000	New	+$82.2K	﹤0.01%	1283

Other funds holding CABA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Ritholtz Wealth Management's CABA Position: Q2 2026 in Review

Ritholtz Wealth Management opened a new position in Cabaletta Bio (CABA) in Q2 2026: 25,000 shares worth $77.8K. The stake represents ﹤0.01% of the portfolio and ranks #1283 among its holdings.

140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

Ritholtz Wealth Management held 25,000 shares of Cabaletta Bio worth $77.8K as of Q2 2026.
Cabaletta Bio was a new Ritholtz Wealth Management position in Q2 2026.
Cabaletta Bio made up ﹤0.01% of Ritholtz Wealth Management's portfolio in Q2 2026, its #1283 holding.
140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.